###begin article-title 0
###xml 58 63 <span type="species:ncbi:9606">human</span>
The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 201 206 <span type="species:ncbi:9606">human</span>
###xml 219 222 <span type="species:ncbi:10116">rat</span>
###xml 307 310 <span type="species:ncbi:10116">rat</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 377 382 <span type="species:ncbi:9606">human</span>
Differences in sweet taste perception among species depend on structural variations of the sweet taste receptor. The commercially used isovanillyl sweetener neohesperidin dihydrochalcone activates the human but not the rat sweet receptor TAS1R2+TAS1R3. Analysis of interspecies combinations and chimeras of rat and human TAS1R2+TAS1R3 suggested that the heptahelical domain of human TAS1R3 is crucial for the activation of the sweet receptor by neohesperidin dihydrochalcone.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 166 171 <span type="species:ncbi:9606">human</span>
By mutational analysis combined with functional studies and molecular modeling we identified a set of different amino acid residues within the heptahelical domain of human TAS1R3 that forms the neohesperidin dihydrochalcone binding pocket. Sixteen amino acid residues in the transmembrane domains 2 to 7 and one in the extracellular loop 2 of hTAS1R3 influenced the receptor's response to neohesperidin dihydrochalcone. Some of these seventeen residues are also part of the binding sites for the sweetener cyclamate or the sweet taste inhibitor lactisole. In line with this observation, lactisole inhibited activation of the sweet receptor by neohesperidin dihydrochalcone and cyclamate competitively, whereas receptor activation by aspartame, a sweetener known to bind to the N-terminal domain of TAS1R2, was allosterically inhibited. Seven of the amino acid positions crucial for activation of hTAS1R2+hTAS1R3 by neohesperidin dihydrochalcone are thought to play a role in the binding of allosteric modulators of other class C GPCRs, further supporting our model of the neohesperidin dihydrochalcone pharmacophore.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 99 104 <span type="species:ncbi:9606">human</span>
From our data we conclude that we identified the neohesperidin dihydrochalcone binding site at the human sweet taste receptor, which overlaps with those for the sweetener cyclamate and the sweet taste inhibitor lactisole. This readily delivers a molecular explanation of our finding that lactisole is a competitive inhibitor of the receptor activation by neohesperidin dihydrochalcone and cyclamate. Some of the amino acid positions crucial for activation of hTAS1R2+hTAS1R3 by neohesperidin dihydrochalcone are involved in the binding of allosteric modulators in other class C GPCRs, suggesting a general role of these amino acid positions in allosterism and pointing to a common architecture of the heptahelical domains of class C GPCRs.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 401 403 401 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">B </sub>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 817 818 817 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Genetic, anatomical and functional studies provide compelling evidence that the vast majority of sweet taste perception is mediated by G-protein coupled receptors (GPCR) of the TAS1R-gene family, which comprises the members TAS1R1-3 [1-6]. TAS1Rs belong to the class C GPCRs and are distantly related to the calcium sensing receptor, metabotropic glutamate receptors, V2R pheromone receptors, and GABAB receptors [3]. In situ hybridization studies revealed that TAS1R3 is coexpressed with TAS1R1 or TAS1R2 in taste receptor cells [5,6]. This observation suggests that the functional receptor, like other class C GPCRs [7], may be a heteromer of two subunits. Indeed, functional assays revealed that the combination of TAS1R1+TAS1R3 is activated by umami tasting compounds, while TAS1R2+TAS1R3 responds to sweeteners [4,5,8].
###end p 9
###begin p 10
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1046 1048 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1257 1259 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1649 1651 1649 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1652 1654 1652 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1858 1860 1858 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1936 1938 1936 1938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 2078 2080 2078 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2081 2083 2081 2083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 428 431 <span type="species:ncbi:10116">rat</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
###xml 603 608 <span type="species:ncbi:9606">human</span>
###xml 860 865 <span type="species:ncbi:9606">human</span>
###xml 1105 1108 <span type="species:ncbi:10116">rat</span>
###xml 1149 1154 <span type="species:ncbi:9606">human</span>
###xml 1245 1248 <span type="species:ncbi:10116">rat</span>
###xml 1627 1632 <span type="species:ncbi:9606">human</span>
###xml 1679 1682 <span type="species:ncbi:10116">rat</span>
###xml 1683 1688 <span type="species:ncbi:9606">human</span>
###xml 2349 2354 <span type="species:ncbi:9606">human</span>
The human sweet taste receptor is sensitive to the sweet proteins thaumatin, brazzein and monellin, the artificial sweeteners aspartame and cyclamate as well as to the sweet inhibitor lactisole whereas its rodent homolog is not [4]. This is in line with corresponding variations in sweet perception across species [9-11]. Studies with chimeric receptors revealed that replacement of the large N-terminal extracellular domain of rat Tas1r2 by its human counterpart created a receptor that responded to aspartame and neotame when coexpressed with hTAS1R3. Additional mutations in the N-terminal domain of human TAS1R2 impaired the activation of the sweet taste receptor by aspartame, thus suggesting that the N-terminal part of TAS1R2 is involved in the binding of these sweeteners [12,13]. Similar studies showed that amino acids in the cysteine-rich region of human TAS1R3 that connects the N-terminal extracellular domain to the segment containing the heptahelical domain determines the response to sweet proteins such as brazzein and monellin [12]. Conversely, replacement of the heptahelical domain of rat Tas1r3 by the corresponding part of the human receptor led to a chimera that responded to lactisole and cyclamate when coexpressed with rat Tas1r2 [13]. This suggests that the binding sites for cyclamate and lactisole are located in the heptahelical domain of hTAS1R3. Indeed, mutational analysis in combination with molecular modeling studies of the heptahelical domain of TAS1R3 revealed that the sweet inhibitor lactisole and the sweetener cyclamate have overlapping binding sites in the heptahelical domain of the human TAS1R3 subunit [14,15]. Recently, analysis of rat-human sweet taste receptor chimeras revealed that the heptahelical domain of hTAS1R3 is also crucial for the activation by the sweetener neohesperidin dihydrochalcone (NHDC) [16]. NHDC is added to various foods and beverages as a low caloric sweetener [17], but its use is limited by some unwanted sensory properties such as a delayed onset and a long lingering menthol-licorice like sweetness [18,19]. Thus, a detailed molecular understanding of the interactions of the sweet receptor with NHDC may contribute to the rational design of analogues with improved sensory properties. We therefore investigated the binding pocket of neohesperidin dihydrochalcone at the human sweet taste receptor.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 61 66 <span type="species:ncbi:9606">human</span>
Analysis of receptor chimeras reveals that NHDC requires the human TAS1R3 heptahelical domain
###end title 12
###begin p 13
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1216 1221 1216 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C, D</xref>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 219 222 <span type="species:ncbi:10116">rat</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 544 547 <span type="species:ncbi:10116">rat</span>
###xml 682 685 <span type="species:ncbi:10116">rat</span>
###xml 706 711 <span type="species:ncbi:9606">human</span>
###xml 801 804 <span type="species:ncbi:10116">rat</span>
###xml 881 884 <span type="species:ncbi:10116">rat</span>
The isovanillyl compound NHDC (Fig. 1A) activates the human but not the rodent sweet taste receptor (Fig. 1B). In order to elucidate the putative binding site for NHDC, we cotransfected mixtures of plasmid DNAs for the rat and human TAS1R2 and TAS1R3 receptor subunits in HEK293T cells stably expressing the chimeric G-protein G16Gust44 and measured cellular calcium responses by fluorometry following bath application of various sweet tasting compounds. We found that NHDC elicited calcium responses in cells transfected with human TAS1R3 and rat Tas1r2 cDNA, whereas it did not in cells transfected with the opposite combination (Fig. 1C). By replacing the heptahelical domain of rat Tas1r3 with that of human TAS1R3 we produced a chimeric receptor that was sensitive for NHDC when coexpressed with rat Tas1r2 (Fig. 1C). In marked contrast, all receptors that contain the entire rat Tas1r3 or its heptahelical domain did not respond to NHDC (Fig. 1C). Notably, although the amplitudes and the response pattern of the receptor chimaeras varied (for details see Ref. 13, supplement) we can demonstrate that all tested receptor chimeras were functional because they could be activated by at least one sweetener (Fig. 1C, D). These results clearly indicate that the heptahelical domain of TAS1R3 appears to be crucially involved in the activation of the sweet receptor by NHDC.
###end p 13
###begin p 14
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chemical structure and calcium responses elicited by neohesperidin dihydrochalcone</bold>
###xml 455 461 455 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAS1R </italic>
###xml 441 444 <span type="species:ncbi:10116">rat</span>
###xml 449 454 <span type="species:ncbi:9606">human</span>
###xml 549 552 <span type="species:ncbi:10116">rat</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 673 678 <span type="species:ncbi:9606">human</span>
###xml 750 753 <span type="species:ncbi:10116">rat</span>
###xml 813 816 <span type="species:ncbi:10116">rat</span>
###xml 888 893 <span type="species:ncbi:9606">human</span>
Chemical structure and calcium responses elicited by neohesperidin dihydrochalcone. (A) Structure of neohesperidin dihydrochalcone. Numbers denote carbon atom positions. (B) Representative calcium traces elicited upon stimulation with different concentrations of neohesperidin dihydrochalcone (NHDC) in HEK293T-G16Gust44 cells cotransfected with DNA for hTAS1R2/hTAS1R3. (C,D) Calcium responses of cells cotransfected with DNA for different rat and human TAS1R subunits or chimeras upon stimulation with 1 mM NHDC (C), or 30 mM D-Tryptophan (D). R, rat receptor subunit; H human receptor subunit; HR, receptor chimera comprising the N-terminal extra cellular domain of the human receptor subunit fused to the corresponding heptahelical domain of the rat; RH, comprising the N-terminal extracellular domain of the rat receptor subunit fused to the corresponding heptahelical domain of the human receptor.
###end p 14
###begin title 15
Receptor activation by NHDC is competitively inhibited by lactisole
###end title 15
###begin p 16
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 708 709 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Recently, it has been shown that the binding sites for the sweetener cyclamate and the sweet inhibitor lactisole overlap in the heptahelical domain of TAS1R3 [14,15]. We therefore reasoned that the NHDC binding site might also overlap with that for lactisole. In this case one would expect that lactisole competitively inhibits the activation of hTAS1R2/hTAS1R3 by NHDC and cyclamate. In contrast, receptor activation by sweeteners that bind to other sites should be allosterically inhibited. To verify this assumption we recorded concentration-response curves for NHDC, cyclamate, acesulfame K and aspartame in the presence of different concentrations of lactisole in cells expressing hTAS1R2/hTAS1R3 (Fig. 2).
###end p 16
###begin p 17
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of hTAS1R2/hTAS1R3 by lactisole</bold>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hTAS1R2</italic>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hTAS1R3 </italic>
###xml 349 352 347 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
Inhibition of hTAS1R2/hTAS1R3 by lactisole. (A-D) Concentration responses of cells transfected with hTAS1R2-hTAS1R3 DNAs to sweetners mixed with different lactisole concentrations. No lactisole present (filled circles, solid line), 50 muM lactisole (filled triangles up, dashed line), and 100 muM lactisole (filled squares, dash-dotted line). (E) EC50 values for acesulfame K, aspartame, NHDC, and cyclamate in the absence or presence of 50 muM and 100 muM lactisole.
###end p 17
###begin p 18
###xml 62 65 62 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 140 145 140 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, E</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 516 519 516 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 532 537 532 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, E</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 745 750 745 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C, D</xref>
###xml 796 799 796 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 1512 1514 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 987 992 <span type="species:ncbi:9606">human</span>
In line with these expectations lactisole did not alter the EC50 values for acesulfame K but reduced the signal amplitudes up to ~75% (Fig. 2A, E), suggesting that it is an allosteric inhibitor of acesulfame K. Likewise, lactisole diminished the signal amplitudes induced by aspartame (Fig. 2B), which is consistent with an allosteric inhibition of aspartame-mediated receptor activation. Interestingly, in case of aspartame, the pronounced reductions in signal amplitudes were accompanied by a right-shift in the EC50 values (Fig. 2B, E). This may be due to an influence of lactisole on the aspartame binding site by negative cooperativity [20]. In contrast, lactisole did not diminish the signal amplitudes elicited by NHDC or cyclamate (Fig. 2C, D). Instead, lactisole clearly increased the EC50 values of these compounds ~fourfold (Fig. 2E). This observed competitive inhibition suggests that the binding sites for lactisole, cyclamate and NHDC overlap in the heptahelical domain of human TAS1R3. Interestingly, we observed slope changes for two of the four tested compounds. While Aspartame and Acesulfam K had constant Hill slope of ~2 the Hill coefficient for NHDC in the presence of 0.0 muM, 50 muM or 100 muM lactisole was 0.8, 1.2 and 1.5, respectively. The calculated Hill coefficient for cyclamate was 1.6, 2.5 and 2.7, respectively. This may be best explained by allosteric effects and may therefore indicate the existence of additional interaction sites either for lactisole or for the sweeteners [21].
###end p 18
###begin title 19
NHDC interacts with residues of the lactisole and cyclamate binding site
###end title 19
###begin p 20
###xml 209 213 209 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.28</sup>
###xml 220 224 220 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.36</sup>
###xml 231 235 231 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.42</sup>
###xml 242 246 242 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.46</sup>
###xml 253 257 253 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.36</sup>
###xml 264 268 264 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.52</sup>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex3</sup>
###xml 285 289 285 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.47</sup>
###xml 296 300 296 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 307 311 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 318 322 318 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32</sup>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex2</sup>
###xml 339 343 339 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.43</sup>
###xml 350 354 350 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 372 376 372 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 729 734 729 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.47 </sup>
###xml 813 814 813 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 962 966 962 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.28</sup>
###xml 973 977 973 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.36</sup>
###xml 984 988 984 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.42</sup>
###xml 995 999 995 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.46</sup>
###xml 1006 1010 1006 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.52</sup>
###xml 1017 1020 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex3</sup>
###xml 1027 1031 1027 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.36</sup>
###xml 1042 1045 1042 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1110 1111 1110 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1144 1145 1144 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1280 1284 1280 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 1291 1295 1291 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32</sup>
###xml 1302 1306 1302 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 1313 1316 1313 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex2</sup>
###xml 1323 1327 1323 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.43</sup>
###xml 1334 1338 1334 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 1345 1349 1345 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 1360 1365 1360 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55 </sup>
###xml 1400 1403 1400 1403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1454 1455 1454 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1486 1487 1486 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1587 1590 1587 1590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1635 1636 1635 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1777 1778 1777 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1803 1806 1803 1806 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1830 1834 1830 1834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 1840 1844 1840 1844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 1850 1854 1850 1854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32</sup>
###xml 1860 1863 1860 1863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex2</sup>
###xml 1869 1873 1869 1873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.43</sup>
###xml 1879 1883 1879 1883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 1889 1893 1889 1893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 1899 1904 1899 1904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55 </sup>
Next, we investigated which amino acids of the binding sites for lactisole or cyclamate are critical determinants for receptor activation by NHDC. Therefore, we analyzed the effect of 16 point mutations (Q636A3.28, R723A5.36, S729A5.42, A733V5.46, L798I7.36, V779A6.52, R790Qex3, H734A5.47, Q637E3.29, H641A3.33, S640A3.32, H721Aex2, F730L5.43, W775A6.48, F778A6.51, L782A6.55) in the heptahelical domain of hTAS1R3 that have previously been shown to influence receptor sensitivity to cyclamate or lactisole [14,15] on the sweet receptor's response to NHDC. The effects were measured by recording calcium responses in HEK293T-G16Gust44 cells coexpressing hTAS1R2 and the various hTAS1R3 mutants. Cells expressing the mutant H734A5.47 did not respond to NHDC, cyclamate, aspartame or acesulfame K (Additional file 1). We assumed that this mutation generally impairs the function of the receptor and excluded it from further analyses. Seven receptor mutants (Q636A3.28, R723A5.36, S729A5.42, A733V5.46, V779A6.52, R790Qex3, L798I7.36) showed EC50 values for NHDC similar to that of the wild type receptor (Table 1, normal script, Additional file 2), suggesting that these residues have no impact on the action of NHDC on the sweet receptor. The eight remaining TAS1R3 mutants, Q637E3.29, S640A3.32, H641A3.33, H721Aex2, F730L5.43, W775A6.48, F778A6.51, and L782A6.55 showed at least eightfold higher EC50 values for NHDC than the wild type receptor (Table 1, bold script, Additional file 2). The decreased sensitivities of these eight mutant receptors were specific for NHDC since their EC50 values for aspartame were not altered (Table 1). Additionally, immunocytochemical analysis revealed similar expression patterns for all examined TAS1R3 receptor variants (Additional file 3). Thus, the increased EC50 values suggest that Q6373.29, H6413.33, S6403.32, H721ex2, F7305.43, W7756.48, F7786.51, L7826.55 are important for the activation of the sweet taste receptor by NHDC.
###end p 20
###begin p 21
Effects of various mutations on the activation of the sweet taste receptor by neohesperidin dihydrochalcone (NHDC) and aspartame (ASP)
###end p 21
###begin p 22
###xml 197 200 195 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 266 267 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
Receptor variants that affect the NHDC response are shown in bold. Values are given as average over at least three independent experiments +/- SD. n.f., no response to any tested sweetener. (>), EC50 not calculable because saturation is not reached (Additional file 2).
###end p 22
###begin title 23
Modeling of the NHDC binding site predicts interactions with additional residues in the heptahelical domain of TAS1R3
###end title 23
###begin p 24
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1588 1590 1588 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1591 1593 1591 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2125 2130 2125 2130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33 </sup>
###xml 2136 2138 2136 2138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 2158 2163 2158 2163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33 </sup>
###xml 2235 2237 2235 2237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2464 2469 2464 2469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32 </sup>
###xml 2602 2606 2602 2606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 2612 2616 2612 2616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 2626 2631 2626 2631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 2650 2652 2650 2652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 2766 2771 2766 2771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58 </sup>
###xml 2779 2783 2779 2783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.61</sup>
###xml 2844 2849 2844 2849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.38 </sup>
###xml 2857 2861 2857 2861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 2892 2894 2892 2894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 3013 3018 3013 3018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.57 </sup>
###xml 3138 3142 3138 3142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 3148 3152 3148 3152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.37</sup>
###xml 3158 3163 3158 3163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.38 </sup>
###xml 3171 3175 3171 3175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39</sup>
###xml 145 151 <span type="species:ncbi:9913">bovine</span>
To further elucidate the binding mode for NHDC, an alignment of the seven transmembrane helices of the hTAS1R3 with the transmembrane helices of bovine rhodopsin was performed (Additional file 4). Amino acids were extracted at helix positions critical for binding of retinal and then combined in a one dimensional amino acid vector, called ligand pocket vector (LPV) [22]. Amino acids in the TAS1R3 LPV were considered as likely candidates to affect binding of NHDC. Classical homology models imply to have the quality of an X-ray crystal structure and therefore overstress specific, in detail unknown, rotamer conformations of the amino acids. Despite of the substantial progress in building homology models and independently of the level of sophistication of the techniques used, there always remains the risk of a mismatch between optimized rotamers and ligand binding requirements, leading to the rejection of ligands in docking experiments. We therefore designed a simple TM binding pocket pharmacophore (Fig. 3A) to avoid atomic details tending to mask this inherent uncertainty and to concentrate on the general topology of the binding site and the approximate relative orientation of charged, donor/acceptor and neutral side chains. Only amino acid residues are shown which were identified as important for the action of NHDC by site-directed mutagenesis. NHDC was manually docked into the pharmacophore. For the docking process in addition to our results also data from structure-activity relationships of ring substituted dihydrochalcone sweeteners reported by Whitelaw et al. [23,24] were taken into account. These studies reported that the hydroxyl group in the B ring system at C3 of 3'-carboxyhesperitin dihydrochalcone is essential for its sweet taste. Moreover, the introduction of a carboxylic acid at the C3' position in the A ring system enhances the sweetness of the dihydrochalcone structure. Projecting this knowledge onto the chemical structure of NHDC suggests that the OH group in the C3 position is important for receptor-ligand interactions and the C3' position should be in close proximity to H6413.33 (Fig. 3A). Furthermore, H6413.33 was already proposed to interact with the carboxylic acid of lactisole [15] and the mutational studies of the present report indicate that the binding pockets of these two compounds do indeed overlap. The proposed binding mode of NHDC also suggests an interaction of the hydroxyl group at C3 with S6403.32 and the hydroxyl groups at C6' and C2' of NHDC could potentially interact with polar amino acids located in TM3 and TM7, such as H6413.33, Q6373.29, and C8017.39 respectively (Fig. 3A). In addition, favorable hydrophobic interactions between the B phenyl ring of NHDC could be envisioned with V6212.58 and F6242.61, and between the linker of the A and B phenyl ring with L8007.38 and G8047.42. Furthermore, the model (Fig. 3A) predicts additional putative interaction sites, such as an interaction between the C3-hydroxylgroup of NHDC with S6202.57 in TM2. Moreover, the polar sugar moieties of NHDC could be interacting with polar amino acids of TM4 and TM5, e.g. Y6994.60, T7245.37, R7255.38 and S7265.39.
###end p 24
###begin p 25
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Three dimensional on top view of the TAS1R3 heptahelical domain binding pocket model</bold>
Three dimensional on top view of the TAS1R3 heptahelical domain binding pocket model. The binding pocket is docked with NHDC (A), lactisole (B), and cyclamate (C). Intra- and extra cellular loops are removed and the helices are directly connected. The transmembrane segments (TM1-TM7) are denoted in orange. Important residues are labeled in Ballesteros-Weinstein nomenclature in addition to the one letter amino acid code. Amino acids that influence the activation of the sweet receptor by NHDC are shown as spheres. The size of the spheres corresponds to the size of the side chain. The spheres are colored according to their pharmacophoric properties. Hydrophobic amino acids (F, P, M, A, L, I, G, V, W) cyan, H-donor/acceptor (Y, T, S, H, C, N, Q) magenta, H-bond donors with a positive charge (R) blue. Possible H-bond interactions are presented as dotted lines The color of the dotted lines indicate the energy of a H-bond, blue indicates an energy of -0.3-0.6 kcal/Mol, magenta: -0.6-1.2 kcal/Mol, red: -1.2-2.4 kcal/Mol. C atoms of NHDC are displayed in white and oxygen in red. Amino acid positions printed in red refer to residues emerged from the first round of mutational analysis and have been used as anchor points. Amino acid positions printed in grey were predicted from the model to influence receptor activation by NHDC and have been verified by mutational analysis.
###end p 25
###begin title 26
Validation of the model by functional analysis of additional mutants
###end title 26
###begin p 27
###xml 93 97 93 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.57</sup>
###xml 103 107 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58</sup>
###xml 113 117 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.61</sup>
###xml 123 127 123 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 133 137 133 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.37</sup>
###xml 143 147 143 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.38</sup>
###xml 153 157 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39</sup>
###xml 163 167 163 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.38</sup>
###xml 173 177 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 187 191 187 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 368 372 368 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.57</sup>
###xml 379 383 379 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58</sup>
###xml 390 394 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58</sup>
###xml 401 405 401 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.61</sup>
###xml 412 416 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 423 427 423 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 434 438 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.37</sup>
###xml 445 449 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.38</sup>
###xml 456 460 456 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39</sup>
###xml 467 471 467 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.38</sup>
###xml 478 482 478 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 489 493 489 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 500 504 500 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 515 519 515 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 683 688 683 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58 </sup>
###xml 697 702 697 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 928 933 928 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.38 </sup>
###xml 1004 1005 1004 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1023 1024 1023 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1125 1129 1125 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.57</sup>
###xml 1136 1140 1136 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58</sup>
###xml 1147 1151 1147 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.61</sup>
###xml 1158 1162 1158 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 1169 1173 1169 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 1180 1184 1180 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.37</sup>
###xml 1191 1195 1191 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.38</sup>
###xml 1202 1206 1202 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39</sup>
###xml 1213 1217 1213 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 1228 1232 1228 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 1271 1274 1271 1274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1297 1298 1297 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1329 1330 1329 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1353 1357 1353 1357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 1418 1419 1418 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1437 1438 1437 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1443 1444 1443 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1533 1536 1533 1536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1564 1565 1564 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1694 1695 1694 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1713 1714 1713 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1738 1741 1738 1741 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
To verify the predictions of the model we selected 10 additional amino acids in hTAS1R3 (S6202.57, V6212.58, F6242.61, Y6994.60, T7245.37, R7255.38, S7265.39, L8007.38, C8017.39, and G8047.42) as candidates that might also influence the activation of the sweet receptor by NHDC. To test their impact on the receptor function we created fourteen hTAS1R3 variants (S620A2.57, V621L2.58, V621I2.58, F624L2.61, Y699L4.60, Y699F4.60, T724L5.37, R725M5.38, S726A5.39, L800F7.38, C801I7.39, C801L7.39, G804A7.42, and G804V7.42) and tested their responses to NHDC by calcium imaging after coexpression with hTAS1R2 in HEK293T-G16Gust44 cells. The results show that the mutant receptors V621L2.58 and C801L7.39 could not be activated by NHDC, cyclamate, aspartame and acesulfame K (Table 2, Additional file 1), suggesting that these mutants are not functional. Therefore, we excluded them from further analyses. The receptor mutant L800F7.38 responded to NHDC in a manner similar to the wild type receptor (Table 2, Additional file 2), suggesting that L800 is not important for receptor activation by NHDC. Ten receptor mutants (S620A2.57, V621I2.58, F624L2.61, Y699L4.60, Y699F4.60, T724L5.37, R725M5.38, S726A5.39, C801I7.39, and G804A7.42) had five to sixteen fold increased EC50 values for NHDC (Table 2, bold script, Additional file 2) and one mutant, G804V7.42, did not respond to NHDC at any tested concentration (Table 2, Additional file 1 and 2). The effects of these mutants were specific for NHDC because they all showed similar EC50 values for aspartame (Table 2). Moreover, the functional differences were not correlated with different expression levels or reduced signal amplitudes (Table 2, Additional file 3). The changes in the EC50 values suggest that these mutations directly affect the activation of the sweet taste receptor by NHDC, thus validating our model.
###end p 27
###begin p 28
Effect of mutations predicted by molecular modeling on the activation of the sweet taste receptor by neohesperidin dihydrochalcone (NHDC) and aspartame (ASP)
###end p 28
###begin p 29
###xml 324 327 322 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 393 394 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
Receptor variants that affect the NHDC response are shown in bold. Values are given as average over at least three independent experiments +/- SD. n.f. no response to any tested sweetener, n.r. no response to neohesperidin dihydrochalcone up to highest tested concentration (6 mM), but responses to other sweeteners. (>), EC50 not calculable because saturation is not reached (Additional file 2).
###end p 29
###begin title 30
Some of the newly identified residues also influence the interaction of the sweet receptor with lactisole or cyclamate
###end title 30
###begin p 31
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 506 510 506 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.28</sup>
###xml 515 519 515 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 524 528 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32</sup>
###xml 533 537 533 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 542 545 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex2</sup>
###xml 550 554 550 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.36</sup>
###xml 559 563 559 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.42</sup>
###xml 568 572 568 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.43</sup>
###xml 577 581 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.46</sup>
###xml 586 590 586 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 595 599 595 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.52</sup>
###xml 604 608 604 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 613 616 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex3</sup>
###xml 625 630 625 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.36 </sup>
###xml 890 895 890 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48 </sup>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1054 1059 1054 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 1062 1065 1062 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1090 1095 1088 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60 </sup>
###xml 1098 1101 1096 1099 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1130 1135 1126 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60 </sup>
###xml 1138 1141 1134 1137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1255 1258 1249 1252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1330 1335 1322 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60 </sup>
###xml 1343 1348 1335 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 1435 1440 1427 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 1449 1454 1441 1446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48 </sup>
###xml 1621 1623 1613 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1641 1642 1633 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1683 1688 1675 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39 </sup>
###xml 1751 1754 1743 1746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1794 1797 1786 1789 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
Since our results indicate a partial overlap of the NHDC binding site with those for lactisole and cyclamate, we next asked, if any of the newly identified residues also affect the sweet receptor's responses to these compounds. To this end, we tested all mutant hTAS1R3 subunits by coexpression with hTAS1R2 in HEK293T-G16Gust44 cells for their sensitivity to lactisole and cyclamate (Additional file 1). While we essentially confirmed the findings of Jiang et al. [14,15] that amino acids in positions 6363.28, 6373.29, 6403.32, 6413.33, 721ex2, 7235.36, 7295.42, 7305.43, 7335.46, 7786.51, 7796.52, 7826.55, 790ex3, and 7987.36 of hTAS1R3 contribute to the sensitivity of the sweet receptor to cyclamate and/or lactisole, we found additional amino acids in the heptahelical domain of hTAS1R3 that altered the responses of the sweet receptor to the two compounds. The mutant receptor W775A6.48 failed to respond to lactisole (Fig. 4A), suggesting that this residue is crucial for the sensitivity of the sweet receptor to the inhibitor. The mutants C801I7.39 (IC50 = 0.3 +/- 0.01 mM), Y699L4.60 (IC50 = 0.3 +/- 0.01 mM), and Y699F4.60 (IC50 = 0.5 +/- 0.01 mM) showed three- to fivefold reduced responses to lactisole compared to the wild type receptor (IC50 = 0.1 +/- 0.01 mM). Thus, we conclude that the amino acid positions Y6994.60 and C8017.39 also contribute to the inhibition of the sweet receptor by lactisole. The mutants C801I7.39 and W775A6.48 could not be activated at any tested concentration of cyclamate indicating the importance of these residues for the sweet receptor's responsiveness to cyclamate (Fig. 4B, Additional file 1). In addition, the mutant receptor S726A5.39 displayed more than fivefold lower sensitivity to cyclamate (EC50 > 10 mM) than the wild type receptor (EC50 = 1.9 +/- 0.1 mM), suggesting that all three residues contribute to the receptor's ability to be activated by cyclamate.
###end p 31
###begin p 32
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of additional determinants in TAS1R3 critical for responsiveness to cyclamate and lactisole</bold>
###xml 314 319 314 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 359 364 359 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.60 </sup>
###xml 406 411 406 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.60 </sup>
###xml 461 466 461 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48 </sup>
###xml 665 670 665 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39 </sup>
###xml 715 720 715 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 763 768 763 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48 </sup>
Identification of additional determinants in TAS1R3 critical for responsiveness to cyclamate and lactisole. (A) Concentration-dependent inhibition of calcium responses to 10 mM aspartame by lactisole in HEK293T-G16Gust44 cells cotransfected with DNA for wild type hTAS1R2/hTAS1R3 (filled circle, solid line), C801I7.39 (open diamond, short dashed line), Y699L5.60 (open circle, dash-dot-dotted line), Y699F5.60 (filled triangle up, medium dashed line), or W775A6.48 (filled hexagon, dash-dotted line) and hTAS1R2 DNA. (B) Concentration-dependent responses of HEK293T-G16Gust44 cells to cyclamate cotransfected with DNA for hTAS1R3 (filled circle, solid line), S726A5.39 (open triangle up, medium dashed line), C801I7.39 (open diamond, short dashed line), or W775A6.48 (filled hexagon, dash-dotted line) and hTAS1R2.
###end p 32
###begin title 33
Discussion
###end title 33
###begin title 34
NHDC binds in the heptahelical domain of TAS1R3
###end title 34
###begin p 35
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 889 890 889 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 893 894 893 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1287 1288 1287 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1362 1364 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1368 1370 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 450 453 <span type="species:ncbi:10116">rat</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 583 588 <span type="species:ncbi:9606">human</span>
###xml 665 668 <span type="species:ncbi:10116">rat</span>
###xml 1016 1021 <span type="species:ncbi:9606">human</span>
###xml 1049 1052 <span type="species:ncbi:10116">rat</span>
###xml 1257 1260 <span type="species:ncbi:10116">rat</span>
###xml 1265 1270 <span type="species:ncbi:9606">human</span>
Several independent lines of evidence clearly demonstrate that NHDC interacts with specific amino acid residues in the heptahelical domain of the TAS1R3 subunit. First, lactisole, which interacts with the heptahelical domain of TAS1R3 [13,15], inhibited the activation of hTAS1R2/hTAS1R3 by NHDC competitively, while sweeteners that interact with other parts of the receptor were allosterically inhibited (Fig. 2). Second, the functional analysis of rat/human TAS1R2/TAS1R3 chimeric receptors showed that NHDC activated all chimeric receptors that contain the heptahelical domain of human TAS1R3. In contrast, all chimeras that contained the heptahelical domain of rat Tas1r3 could not be activated by NHDC (Fig. 1). Third, seventeen amino acid exchanges in the heptahelical domain of hTAS1R3 specifically reduced the NHDC responses but did not influence the responses to aspartame (Table 1 + 2), which interacts with the extracellular N-terminal domain of TAS1R2 [13]. Moreover, the finding that NHDC activates the human sweet receptor but not the rat sweet taste taste receptor delivers a molecular basis for the well-known lack of NHDC preference in rodents [25,26]. In addition, our results confirm previous findings that functional differences between rat and human sweet receptor [4] are caused by sequence variations in the heptahelical domain of TAS1R3 [13,14,16].
###end p 35
###begin title 36
Elucidation of the NHDC binding site
###end title 36
###begin p 37
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1009 1014 1009 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32 </sup>
###xml 1028 1033 1028 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.57 </sup>
To further understand the interaction between NHDC and the heptahelical domain of hTAS1R3 we established a simple 3D receptor pharmacophore model of the NHDC binding site. Notably, in the model each amino acid residue in the heptahelical domain of the TAS1R3 receptor is identified by its position. Moreover, the numbering system proposed by Ballesteros and Weinstein [27] is shown as superscripts to facilitate the comparison with results of other GPCRs. The model considers results obtained from our functional studies, available data about the suggested binding modes of cyclamate and lactisole [14,15], information about conserved amino acids in GPCRs [27], and sensory studies of NHDC derivatives [23,24]. These sensory studies have shown that the hydroxyl group in C3 of the B ring is crucial for the sweet taste of dihydrochalcones [23,28]. In line with these findings, our receptor model proposes that this hydroxyl group can form hydrogen bonds with either of the two serine residues in positions 6403.32 of TM3 and 6202.57 of TM2. The possible interaction of the C3 hydroxyl group with both serines can explain why mutations at either position strongly reduced but not completely abolished the responses of the receptor to NHDC.
###end p 37
###begin p 38
###xml 33 37 33 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 57 62 57 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 153 156 153 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 295 299 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 305 309 305 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.38</sup>
###xml 319 324 319 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39 </sup>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 805 810 805 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58 </sup>
###xml 818 823 818 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.61 </sup>
###xml 968 971 968 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
The model also predicts that H6413.33, Q6373.29, and C8017.39 can form hydrogen bonds with hydroxyl groups in the A ring as suggested by the decreased EC50 values for NHDC of the corresponding mutants. In addition, our model predicts that hydroxyl groups of the sugar moieties interact with Y6994.60, R7255.38, and S7265.39 in TM4 and TM5. Indeed, mutations in these positions impaired the interaction of NHDC with the receptor. Notably, the aglycon hesperitin dihydrochalcone that lacks the sugar rings also tastes sweet [29,30]. Therefore, it might be conceivable that amino acids at these three positions are less important for the activation of the sweet taste receptor by NHDC, but rather enhance its affinity. Furthermore, the methoxy group at position C4 of the B ring is in close proximity to V6212.58 and F6242.61 and is therefore likely engaged in favorable hydrophobic interactions with the side chains of these amino acids as concluded from the shift in EC50 values for NHDC at the corresponding mutant receptors.
###end p 38
###begin title 39
The binding sites for NHDC, cyclamate and lactisole share amino acid residues
###end title 39
###begin p 40
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 713 717 713 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 723 727 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 733 737 733 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 743 747 743 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 753 757 753 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex3</sup>
###xml 777 781 777 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 898 899 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 907 908 907 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1063 1064 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1178 1182 1178 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 1188 1192 1188 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32</sup>
###xml 1198 1202 1198 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 1208 1212 1208 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 1218 1222 1218 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 1228 1232 1228 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 1238 1242 1238 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 1252 1256 1252 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 1368 1372 1368 1372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 1378 1382 1378 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 1388 1391 1388 1391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex2</sup>
###xml 1397 1401 1397 1401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39</sup>
###xml 1407 1411 1407 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.43</sup>
###xml 1417 1421 1417 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 1427 1431 1427 1431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 1437 1441 1437 1441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 1451 1455 1451 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 1505 1509 1505 1509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 1515 1519 1515 1519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 1525 1529 1525 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 1535 1539 1535 1539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 1545 1549 1545 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 1559 1563 1559 1563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 1658 1659 1658 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1667 1668 1667 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1671 1672 1671 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 495 501 <span type="species:ncbi:9606">humans</span>
The sweet inhibitor lactisole, which interacts with specific residues in the heptahelical domain of TAS1R3 [13,15,16], inhibited the activation of the sweet receptor by NHDC and cyclamate competitively (Fig. 2). These results suggest that the binding sites of lactisole, cyclamate, and NHDC overlap. Interestingly, the observed competitive effects between NHDC and lactisole (Fig. 2) may also explain why lactisole in contrast to many other sweeteners did not inhibit the sweet taste of NHDC in humans [31]. A previous report of Jiang et al. proposed that cyclamate and lactisole interact with a common set of amino acid residues[14,15]. Our findings confirm this observation by showing that seven mutations (Q6373.29, H6413.33, W7756.48, F7786.51, L7826.55, R790Qex3, and C8017.39) influence both, the lactisole mediated inhibition and the cyclamate induced activation of the sweet receptor (Fig. 5, Table 1 + 2). While cyclamate and lactisole only use parts of the TAS1R3 pharmacophore, our model predicts that NHDC uses most of it due to its larger size (Fig. 3). In line with these predictions, eight of the seventeen amino acids that alter receptor activation by NHDC (Q6373.29, S6403.32, H6413.33, Y6994.60, W7756.48, F7786.51, L7826.55, and C8017.39), also influence lactisole-mediated inhibition of the receptor. Similarly, nine of the seventeen residues (Q6373.29, H6413.33, H721ex2, S7265.39, F7305.43, W7756.48, F7786.51, L7826.55, and C8017.39) mediate activation by cyclamate, while six (Q6373.29, H6413.33, W7756.48, F7786.51, L7826.55, and C8017.39) influence receptor inhibition by lactisole as well as receptor activation by cyclamate (Fig. 5, Table 1 + 2).
###end p 40
###begin p 41
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of the heptahelical domain of hCaSR, hmGlu2, rmGlu1, rmGlu5, and hTAS1R3</bold>
Alignment of the heptahelical domain of hCaSR, hmGlu2, rmGlu1, rmGlu5, and hTAS1R3. Transmembrane segments (TM) are shown in bold. Intra- and extracellular loops are marked by ICL and ECL, respectively. Amino acids that influence allosteric modulator activity in hCaSR, hmGlu2, rmGlu1 and 5 are marked in grey. Positions that alter the response of the sweet receptor to lactisole, cyclamate, or NHDC are shown in red. Asterisks indicate residues involved in receptor activation by NHDC (orange) or cyclamate (blue). Green asteriks denote residues mediating sensitivity of the receptor to lactisole.
###end p 41
###begin p 42
###xml 117 121 117 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 127 131 127 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39</sup>
###xml 137 141 137 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 151 155 151 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Our mutational analysis identified four additional amino acid residues that have not previously been recognized (Y6994.60, S7265.39, W7756.48, and C8017.39) as interaction partners for lactisole and cyclamate [14,15]. These residues nicely refine the model proposed by Jiang et al. by enabling additional interactions between the two compounds and TAS1R3. This finding supports the validity of our model and suggests that it is compatible with that of Jiang et al.
###end p 42
###begin p 43
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 150 154 150 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 161 165 161 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 172 176 172 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 187 192 187 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 343 348 343 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51 </sup>
###xml 356 361 356 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48 </sup>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 662 667 662 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55 </sup>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Transmembrane domains six and seven are generally involved in GPCR activation [32-34]. The following observations suggest that the four residues W775A6.48, F778A6.51, L782A6.55, and C801I7.39 of TM6 and TM7 could participate in conformational changes of the sweet taste receptor from the ground to an active state and vice versa. Firstly, F7786.51 and W7756.48 are highly conserved across class A and class C GPCRs [14,15,35]. Secondly, our study showed that mutations at these positions alter the receptor's sensitivities to the agonists NHDC and cyclamate as well as to the inhibitor lactisole. Thirdly, Jiang et al. also found that mutations in position L782A6.55 abolished activation of the sweet taste receptor by cyclamate and enhanced the receptor's responsiveness to the inhibitor lactisole [15].
###end p 43
###begin p 44
###xml 27 32 27 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 248 256 248 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, B, C</xref>
###xml 322 326 322 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 380 384 380 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 390 394 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 404 409 404 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55 </sup>
###xml 421 426 421 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 641 645 641 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.31</sup>
###xml 651 656 651 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.32 </sup>
###xml 664 669 664 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.38 </sup>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
The amino acid residue C8017.39 in TM7 also affects the sensitivity of the sweet taste receptor to cyclamate, NHDC and lactisole. While it is in the proximity of the NHDC and cyclamate binding sites, it is quite remote from that of lactisole (Fig. 3A, B, C). This argues against a direct interaction of lactisole with C8017.39. It is therefore conceivable that in addition to W7756.48, F7786.51, and L7826.55 in TM6, C8017.39 in TM7 may also play a general role in the activation process of the sweet taste receptor. This assumption is further supported by the observation that amino acids in TM7 of the calcium sensing receptor such as V8367.31, Q8377.32 and A8437.38 play a key role in the activation of this receptor [32].
###end p 44
###begin p 45
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 120 124 120 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 140 145 140 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55 </sup>
###xml 154 159 154 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39 </sup>
###xml 411 412 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 461 463 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
Notably, aspartame, which likely interacts with the N-terminal domain of hTAS1R2 [12,13] could activate the mutants W7756.48, F7786.51, L7826.55 and C801I7.39 in a manner, similar to the wild type receptor (Tab. 1 and 2). Therefore, it might be possible that tastants that bind to different receptor sites elicit different types of active confirmations as has been observed before for the activation of the beta2-adrenergic receptor by salbutamol and catechol [36].
###end p 45
###begin title 46
The NHDC binding site overlaps with the binding sites of allosteric modulators in other class C GPCRs
###end title 46
###begin p 47
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
Sequence comparisons revealed that nine of the amino acid positions in hTAS1R3 that influence the sensitivity of the sweet receptor to NHDC, cyclamate or lactisole correspond to residues that are responsible for binding allosteric modulators in the calcium sensing receptor and metabotropic glutamate receptors (Fig. 5) [32-34,37-43]. This suggests a general role for these positions in allosterism in this class of receptors and shows that positions of allosteric binding sites are partly conserved amongst class C GPCRs. Thus, critical determinants found in non-taste receptors are good candidates to uncover additional binding sites for sweet and umami tasting substances or modulators.
###end p 47
###begin title 48
Conclusion
###end title 48
###begin p 49
###xml 148 153 <span type="species:ncbi:9606">human</span>
Our mutational analysis combined with functional studies and molecular modeling identified the binding pocket of NHDC in the heptahelical domain of human TAS1R3. We found that the binding pocket of NHDC overlaps with those of the sweetener cyclamate and the sweet taste inhibitor lactisole. Seven of the amino acid positions crucial for activation of hTAS1R2/hTAS1R3 by neohesperidin dihydrochalcone are involved in the binding of allosteric modulators of other class C GPCRs. This suggests a general role of these amino acid positions in allosterism and points to a common architecture of the heptahelical domains of class C GPCRs.
###end p 49
###begin title 50
Methods
###end title 50
###begin title 51
Ballesteros and Weinstein nomenclature
###end title 51
###begin p 52
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
The position of each amino acid residue in the heptahelical domain of TAS1R3 is identified both by its position and by the generic numbering system proposed by Ballesteros and Weinstein [27] shown as superscripts. In the Ballesteros-Weinstein nomenclature the most conserved residue in each helix is given the number 50. This is N1.50, D2.50, R3.50, W4.50, P5.50, P6.50 and P7.50 in transmembrane helix 1-7 of the rhodopsin receptor. The corresponding amino acids in the TAS1R3 are given the same numbers (Additional file 4).
###end p 52
###begin title 53
Construction of TAS1R3 mutants
###end title 53
###begin p 54
###xml 334 338 334 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.57</sup>
###xml 345 349 345 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58</sup>
###xml 356 360 356 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.58</sup>
###xml 367 371 367 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.61</sup>
###xml 378 382 378 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.28</sup>
###xml 389 393 389 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.29</sup>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.32</sup>
###xml 411 415 411 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3.33</sup>
###xml 422 426 422 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 433 437 433 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4.60</sup>
###xml 444 447 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex2</sup>
###xml 454 458 454 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.36</sup>
###xml 465 469 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.37</sup>
###xml 476 480 476 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.38</sup>
###xml 487 491 487 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.39</sup>
###xml 498 502 498 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.42</sup>
###xml 509 513 509 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.43</sup>
###xml 520 524 520 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.46</sup>
###xml 531 535 531 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5.47</sup>
###xml 542 546 542 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.48</sup>
###xml 553 557 553 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.51</sup>
###xml 564 568 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.52</sup>
###xml 575 579 575 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6.55</sup>
###xml 586 589 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex3</sup>
###xml 596 600 596 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.36</sup>
###xml 607 611 607 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.38</sup>
###xml 618 622 618 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 629 633 629 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.39</sup>
###xml 640 644 640 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 655 659 655 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.42</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TAS1R3 receptor mutants were generated by site directed mutagenesis according to the QuickChange protocol (Stratagene, La Jolla, CA). The forward and reverse primers contained the desired mutations and annealed to the same sequence on opposite strands of the plasmids. The following TAS1R3 receptor mutants were generated: S620A2.57, V621L2.58, V621I2.58, F624L2.61, Q636A3.28, Q637E3.29, S640A3.32, H641A3.33, Y699L4.60, Y699F4.60, H721Aex2, R723A5.36, T724L5.37, R725M5.38, S726A5.39, S729A5.42, F730L5.43, A733V5.46, H734A5.47, W775A6.48, F778A6.51, V779A6.52, L782A6.55, R790Qex3, L798I7.36, L800F7.38, C801L7.39, C801I7.39, G804V7.42, and G804A7.42.
###end p 54
###begin p 55
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The position of each amino acid residue in the seven heptahelical domain of the TAS1R3 receptor is identified both by its position and by the generic numbering system proposed by Ballesteros and Weinstein [27] shown as superscripts.
###end p 55
###begin title 56
Functional expression
###end title 56
###begin p 57
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 671 674 670 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2, </sub>
###xml 1328 1331 1323 1326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1337 1340 1332 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1441 1443 1436 1438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nH</sup>
###xml 1473 1474 1468 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1473 1475 1468 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>n</italic>H</sup>
The cDNAs for TAS1Rs tagged at the C-terminus with the herpes simplex virus glycoprotein D (HSV) were transiently transfected into HEK293T cells stably expressing the chimeric G-protein subunit G16Gust44 [44] using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. 3-4 hours after transfection, DMEM was replaced by low-glucose DMEM supplemented with GlutaMAX and 10% dialyzed FBS (Invitrogen, Carlsbad, CA). 24 h post transfection, cells were loaded for 1 h with the calcium sensitive dye Fluo4-AM (2 mug/ml in DMEM, Molecular Probes, Carlsbad, CA). Cells were washed 3x in solution C1 (130 mM NaCl, 5 mM KCl, 10 mM Hepes, 2 mM CaCl2, and 5 mM Glucose, pH 7,4). We monitored calcium mobilization following receptor stimulation with sweet tastants by an automated fluorometric imaging plate reader (FLIPR, Molecular Devices, Sunnyvale, CA). Compounds used as stimuli (Sigma-Aldrich, St. Louis, MO; Merck, Whitehouse Station, NJ) were dissolved in C1 solution. All data were collected from at least three independent experiments carried out in duplicate. The obtained calcium signals were corrected for the response of mock transfected cells and normalized to the fluorescence of cells prior to the application of the stimulus using DeltaF/F = (F-F0)/F0. Concentration-response curves and EC50 and IC50 values were calculated in SigmaPlot by nonlinear regression using the function f = ((a-d)/(1+(x/EC50)nH)+d) and f = (a-b)/[1+(x/IC50)nH]+b, respectively.
###end p 57
###begin title 58
Immuncytochemistry
###end title 58
###begin p 59
###xml 268 272 <span type="species:ncbi:9925">goat</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 433 437 <span type="species:ncbi:9925">goat</span>
###xml 576 580 <span type="species:ncbi:9925">goat</span>
###xml 599 604 <span type="species:ncbi:10090">mouse</span>
###xml 656 660 <span type="species:ncbi:9925">goat</span>
HEK293T-G16Gust44 cells were seeded on poly-D-lysine coated coverslips (10 mug/ml) and transfected with the respective cDNAs. 24 h post transfection cells were washed with PBS and fixed and permeabilized for 5 min in acetone/methanol (1:1). Incubating the cells in 5% goat serum for 30 min reduced non-specific binding. To detect the receptors, antiserum against the HSV-epitope (mouse anti-HSV (Novagen, Madison, WI), 1:10000 in 3% goat serum) was added to the cells for 1 h at room temperature (RT). After washing the cells three times with PBS we added Alexa488-conjugated goat antiserum against mouse IgG (Molecular Probes, Carlsbad, CA), 1:1000 in 3% goat serum) for 1 h at RT. The cells were embedded in Fluorescent Mounting Medium (Dako, Glostrup, Denmark) and analyzed using a fluorescence microscope (Zeiss Axioplan, Jena, Germany) and a camera (RT Slide, Visitron Systems, Munich, Germany).
###end p 59
###begin title 60
TAS1R3 modeling
###end title 60
###begin p 61
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1758 1760 1758 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 280 286 <span type="species:ncbi:9913">bovine</span>
All modeling calculations were made on a Silicon Graphics Octane with a single R12000 processor using our in-house modeling package Moloc [45]. The alignment of the seven transmembrane helices of TAS1R3 receptor (SWISS-PROT: TS1R3_HUMAN, Q7RTX0) with the transmembrane helices of bovine rhodopsin (pdb ref code 1f88) and the 3D receptor-based pharmacophore modeling was described previously [22]. Briefly, the method relies on a robust alignment algorithm based on conservation indices, focusing on pharmacophore-like relationships between amino acids. Analysis of conservation patterns across the GPCR family and alignment to the rhodopsin x-ray structure (pdb ref code 1f88, Additional file 4) allows the extraction of the amino acids lining the TM binding pocket in a so-called ligand binding pocket vector. In a second step, LPVs are translated to simple 3D receptor pharmacophore models, where a single spherical pharmacophore feature represents each amino acid and all atomic detail is omitted. The pharmacophores are colored according to the pharmacophoric properties of the amino acids. Hydrophobic amino acids (aromatic/aliphatic; F, P, M, A, L, I, G, V, W) are represented by cyan pharmacophores, amino acids with H-donor/acceptor functionalities (Y, T, S, H, C, N, Q) by magenta pharmacophores, and amino acids with H-bond donor functionalities and positive charge (K, R) by blue ones. The pharmacophores with H-bond donor or acceptor properties have in addition a cone, which gives the most likely direction of the H-bond. The new reported receptor-based pharmacophore modeling methodology allows a visual analysis of the general ligand binding properties of any GPCR without the need to concentrate on atomic details of side chain orientations [22]. NHDC is manually docked into the pharmacophores in the TM pocket. Only pharmacophores are shown which were identified as important for the action of NHDC by site-directed mutagenesis.
###end p 61
###begin title 62
Abbreviations
###end title 62
###begin p 63
NHDC - neohesperidin dihydrochalcone
###end p 63
###begin p 64
GPCR - G-protein coupled receptor
###end p 64
###begin p 65
TAS1R - taste receptor family one
###end p 65
###begin p 66
###xml 20 25 <span type="species:ncbi:9606">human</span>
HEK293T-G16Gust44 - human embryonal kidney cell line stably expressing the large T antigen and the G-protein chimera G16Gust44
###end p 66
###begin p 67
###xml 2 5 2 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
EC50 - half maximal effective concentration
###end p 67
###begin p 68
###xml 2 5 2 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
IC50 - half maximal inhibitory concentration
###end p 68
###begin p 69
FLIPR - fluorometric imaging plate reader
###end p 69
###begin title 70
Competing interests
###end title 70
###begin p 71
The author(s) declares that there are no competing interests.
###end p 71
###begin title 72
Authors' contributions
###end title 72
###begin p 73
MW cloned most of the TAS1R subunits, constructed the chimeric TAS1R3 receptors, carried out the functional and histological studies and participated in the study design. BB coordinated the study design, hold and organized the external collaborations and drafted the manuscript. NAK did the molecular modeling and suggested several sites for receptor mutation. JPS participated in the study design. WM conceived the study, participated in its design, and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 73
###begin title 74
Supplementary Material
###end title 74
###begin title 75
Additional file 1
###end title 75
###begin p 76
Activity of all mutants towards different sweeteners.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Additional file 2
###end title 78
###begin p 79
Concentration-response curves of all mutants towards NHDC.
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Additional file 3
###end title 81
###begin p 82
Expression of hTAS1R3 variants.
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Additional file 4
###end title 84
###begin p 85
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 39 45 <span type="species:ncbi:9913">bovine</span>
Sequence alignment of human TAS1R3 and bovine rhodopsin transmembrane segments (TM).
###end p 85
###begin p 86
Click here for file
###end p 86
###begin title 87
Acknowledgements
###end title 87
###begin p 88
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(</italic>
###xml 223 226 <span type="species:ncbi:10116">rat</span>
The authors gratefully acknowledge Stefanie Demgensky, and Ellen Scholey Pohl for expert technical assistance. We thank Dietmar Krautwurst for his helpful comments and discussion. We are grateful to Hartwig Schmale for the rat Tas1r3 cDNA. This research was supported in part by the German Science Foundation (ME 1024/1-2 and ME 1024/2-1).
###end p 88
###begin article-title 89
A candidate taste receptor gene near a sweet taste locus
###end article-title 89
###begin article-title 90
Detection of sweet and umami taste in the absence of taste receptor T1r3
###end article-title 90
###begin article-title 91
Putative mammalian taste receptors: a class of taste-specific GPCRs with distinct topographic selectivity
###end article-title 91
###begin article-title 92
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human receptors for sweet and umami taste
###end article-title 92
###begin article-title 93
Mammalian sweet taste receptors
###end article-title 93
###begin article-title 94
Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac
###end article-title 94
###begin article-title 95
Roles of G-protein-coupled receptor dimerization
###end article-title 95
###begin article-title 96
An amino-acid taste receptor
###end article-title 96
###begin article-title 97
###xml 108 118 <span type="species:ncbi:10141">guinea pig</span>
###xml 123 126 <span type="species:ncbi:10116">rat</span>
Electrophysiological study of the gustatory effects of the sweet proteins monellin and thaumatin in monkey, guinea pig and rat
###end article-title 97
###begin article-title 98
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats show only a weak preference for the artificial sweetener aspartame
###end article-title 98
###begin article-title 99
###xml 73 79 <span type="species:ncbi:9606">humans</span>
###xml 92 96 <span type="species:ncbi:10116">rats</span>
Cypha [propionic acid, 2-(4-methoxyphenol) salt] inhibits sweet taste in humans, but not in rats
###end article-title 99
###begin article-title 100
The cysteine-rich region of T1R3 determines responses to intensely sweet proteins
###end article-title 100
###begin article-title 101
Different functional roles of T1R subunits in the heteromeric taste receptors
###end article-title 101
###begin article-title 102
###xml 88 93 <span type="species:ncbi:9606">human</span>
Identification of the cyclamate interaction site within the transmembrane domain of the human sweet taste receptor subunit T1R3
###end article-title 102
###begin article-title 103
###xml 54 59 <span type="species:ncbi:9606">human</span>
Lactisole interacts with the transmembrane domains of human T1R3 to inhibit sweet taste
###end article-title 103
###begin article-title 104
###xml 118 121 <span type="species:ncbi:10116">rat</span>
Valine 738 and lysine 735 in the fifth transmembrane domain of rTas1r3 mediate insensitivity towards lactisole of the rat sweet taste receptor
###end article-title 104
###begin article-title 105
Dihydrochalcone sweeteners. Synthesis and sensory evaluation of sulfonate derivatives
###end article-title 105
###begin article-title 106
Dihydrochalcone sweeteners. A study of the atypical temporal phenomena
###end article-title 106
###begin article-title 107
Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR
###end article-title 107
###begin article-title 108
###xml 77 82 <span type="species:ncbi:9606">human</span>
From small sweeteners to sweet proteins: anatomy of the binding sites of the human T1R2_T1R3 receptor
###end article-title 108
###begin article-title 109
An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application
###end article-title 109
###begin article-title 110
Synthesis and sensory evaluation of ring-substituted dihydrochalcone sweeteners. 2. Analogues of 3'-Carboxyhesperetin dihydrocahlcone, a high-potency dihydrochalcone sweetener
###end article-title 110
###begin article-title 111
Synthesis and sensory evaluation of ring-substituted dihydrochalcone sweeteners
###end article-title 111
###begin article-title 112
###xml 52 56 <span type="species:ncbi:10116">rats</span>
###xml 61 67 <span type="species:ncbi:9557">baboon</span>
Taste responses to neohesperidin dihydrochalcone in rats and baboon monkeys
###end article-title 112
###begin article-title 113
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Sweetener preference of C57BL/6ByJ and 129P3/J mice
###end article-title 113
###begin article-title 114
Integrated Methods for the Construction of Three-Dimensional Models and Computational Probing of Structure-Function Relations in G-Protein-Coupled Receptors.
###end article-title 114
###begin article-title 115
Isovanillyl sweeteners. From molecules to receptors
###end article-title 115
###begin article-title 116
Nonnutritive sweeteners: taste-structure relationships for some new simple dihydrochalcones
###end article-title 116
###begin article-title 117
###xml 28 33 <span type="species:ncbi:2708">lemon</span>
Flavonoids of the Ponderosa lemon
###end article-title 117
###begin article-title 118
Selective inhibition of sweetness by the sodium salt of +/-2-(4-methoxyphenoxy)propanoic acid
###end article-title 118
###begin article-title 119
###xml 50 55 <span type="species:ncbi:9606">human</span>
A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+
###end article-title 119
###begin article-title 120
Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor
###end article-title 120
###begin article-title 121
Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca(2+)-sensing receptor
###end article-title 121
###begin article-title 122
Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors
###end article-title 122
###begin article-title 123
Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists
###end article-title 123
###begin article-title 124
###xml 102 107 <span type="species:ncbi:9606">human</span>
Identification of acidic residues in the extracellular loops of the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+ and a positive allosteric modulator
###end article-title 124
###begin article-title 125
Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine
###end article-title 125
###begin article-title 126
###xml 53 58 <span type="species:ncbi:9606">human</span>
Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site
###end article-title 126
###begin article-title 127
The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors
###end article-title 127
###begin article-title 128
Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain
###end article-title 128
###begin article-title 129
###xml 49 54 <span type="species:ncbi:9606">human</span>
Calindol, a positive allosteric modulator of the human Ca(2+) receptor, activates an extracellular ligand-binding domain-deleted rhodopsin-like seven-transmembrane structure in the absence of Ca(2+)
###end article-title 129
###begin article-title 130
Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2
###end article-title 130
###begin article-title 131
Functional interaction between T2R taste receptors and G-protein alpha subunits expressed in taste receptor cells
###end article-title 131
###begin article-title 132
Molecular design software
###end article-title 132

